查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1820174

2025-2033年人工授精市場報告，按類型（子宮內、子宮頸內、陰道內、輸卵管內）、來源類型（AIH-丈夫、AID-捐贈者）、最終用途（醫院和診所、生育中心等）和地區分類

Artificial Insemination Market Report by Type (Intrauterine, Intracervical, Intravaginal, Intratubal), Source Type (AIH-Husband, AID-Donor), End Use (Hospitals and Clinics, Fertility Centers, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球人工授精市場規模達23億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到46億美元，2025-2033年期間的複合年成長率（CAGR）為7.15%。北美是最大的地區，這得益於人們對人工授精優勢的認知不斷提高、人均消費者支出不斷增加以及醫療保健支出不斷增加。此外，不孕率上升、生活方式快速改變以及疾病盛行率不斷上升也是推動市場需求的一些關鍵因素。

人工授精產業正面臨巨大的變化，這得益於技術創新、人們行為的轉變以及各行各業日益廣泛的應用。資料分析在人工授精中的應用日益廣泛，這是改變市場的主要趨勢之一。無論是在人類生育或畜牧養殖業，資料分析都被用來提高人工授精程序的效率和準確性。在人類生育領域，診所現在正在使用巨量資料和人工智慧 (AI) 演算法來確定最佳授精時間、增強精子和卵子的選擇並最大限度地改善胚胎培養環境。透過使用這些資料，生育醫生可以根據患者的獨特需求提供個人化的治療方案，從而增加成功懷孕的可能性。機器學習 (ML) 和人工智慧電腦演算法也被用於對大型資料集進行分類，這有助於進一步了解不孕症模式和改善臨床結果。

人工授精市場趨勢：

人工授精技術的進步

技術創新極大地推動了人工授精市場的發展，提高了人工授精的效率、成功率和可近性。在人類生育治療領域，精子篩選、胚胎培養和冷凍保存技術的進步正在提高人工授精的準確性和有效性。基因篩檢和胚胎分級等方法日益複雜，為接受人工授精生殖治療的患者帶來了更好的治療效果。例如，阿拉伯聯合大公國衛生和預防部 (MoHAP) 宣布，將從 2025 年 1 月初開始，在全國範圍內對所有有意結婚的阿拉伯聯合大公國公民實施強制性基因檢測，並將其作為婚前篩檢計畫的一部分。此外，在畜牧養殖領域，精液冷凍和儲存技術的進步使得優質精液的保存和利用率得到提高。農場人工授精和自動化技術進一步提高了農業人工授精過程的有效性，使農民能夠減少人工授精的干涉。

人工授精在畜牧養殖的應用日益廣泛

人工授精在動物育種中的應用日益廣泛，大大促進了市場的成長。畜牧養殖戶擴大使用人工授精來提高畜群質量，尤其是在牛、豬和家禽方面。人工授精幫助養殖戶選擇性地培育出具有優良特性（例如抗病性強、產奶量高、肉質優良）的動物，從而提高生產力和盈利能力。消費者對食品品質的關注日益加深，對優質肉類和乳製品的需求也隨之成長，這推動了人工授精的應用。人工授精也為改良畜群遺傳和解決近親繁殖問題提供了解決方案，尤其是在遺傳多樣性水平較低的牲畜。 2025年，聯邦內閣批准了修訂後的「國家畜牧業發展計畫」（RGM），以促進畜牧業的發展。更新後的使命將作為發展計畫計劃的中央部門部分執行，新增支出100億盧比，使第十五屆財政委員會（2021-22至2025-26年）期間的總資金達到340億盧比。該計劃將維持其主要職能，包括加強精液站和人工授精網路，利用性別分選精液開展公牛生產和加速品種改良項目，促進技能發展和農民教育工作，以及創建卓越中心並支持中央養牛場。

生育治療需求不斷成長

生育治療需求的不斷成長是人工授精領域（特別是在人類生殖醫學領域）發展的主要驅動力之一。聯合國人口基金（UNFPA）發布的《2025年世界人口狀況報告》（SOWP）題為《真正的生育危機》指出，三分之一的印度成年人（36%）會遭遇意外懷孕，30%的人未能實現生育更多或更少孩子的願望。隨著社會觀念的轉變，大多數人和夫婦因個人或工作原因選擇延後生育，導致不孕症病例增加。這種轉變推動了對輔助生殖技術（ART），例如人工授精的需求。不孕症發病率的不斷上升，通常與生活方式、醫療狀況和環境污染物有關，這進一步刺激了生育治療的需求。隨著人們對解決生育問題的興趣日益濃厚，人工授精越來越被證明是一種關鍵的解決方案，因為它具有非侵入性且成功率高。

人工授精市場成長動力：

政府政策與支持

政府透過實施各種政策和項目，主要在農業和衛生領域推廣人工授精技術的應用，促進了市場成長。在農業領域，許多政府提供補貼、資金獎勵和撥款，以推廣人工授精在育種上的應用。這些政策使農民能夠利用先進的生殖技術，而這些技術原本對他們來說太昂貴。此外，政府還在基礎設施建設方面進行投資，例如為農民和獸醫專家提供人工授精培訓設施，以確保擁有一支熟練的勞動力隊伍，從而促進人工授精的推廣。在人類生育領域，政府擴大向生育診所提供補貼，規範依賴人工授精的生殖技術，並為生育治療提供經濟援助或保險。

社會接受度與文化轉變

社會接受度以及對計劃生育和生育治療態度的文化轉變，正在推動對人工授精的需求。隨著社會價值觀的變化，越來越多的個人和夫婦將職業抱負、高等教育和自我提升置於首要地位，從而推遲了結婚生子的時間。這些趨勢轉化為人工授精等生育治療的使用率上升，因為人們更傾向於避免晚年自然受孕。隨著人們擴大談論生育問題並選擇基於人工授精的方法，對不孕症和輔助生殖技術的污名化也逐漸消退。這種社會態度的轉變使人工授精成為一種更容易被接受的受孕方式。同樣，人工授精正在改變畜牧業的面貌，成為一項主流技術，農民對其增強動物遺傳、最大限度地提高效率和減少碳足跡的能力表示歡迎。

經濟效益和成本效益

經濟條件正成為人工授精產業發展的驅動力，尤其是在畜牧養殖領域。隨著傳統育種技術（例如，飼養大量公牛或進行自然交配）的成本不斷上漲，人工授精正成為降低成本的解決方案。人工授精使農民能夠利用領先公牛的優質基因，而無需繁重的基礎設施，從而將育種成本降至最低。這種經濟實惠的成本正在幫助農民，尤其是發展中國家的農民，提高其農場的獲利能力和生產力。同樣，在人類生育市場，與其他輔助生殖技術相比，人工授精的經濟實惠使其成為大多數人的可行選擇。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球人工授精市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 宮內
  • 子宮頸內
  • 陰道內
  • 輸卵管內

第7章：市場區隔：依來源類型

  • AIH-丈夫
  • AID-捐助者

第 8 章：市場區隔：最終用途別

  • 醫院和診所
  • 生育中心
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Conceivex Inc.
    • FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation)
    • Genea Limited
    • Genus plc
    • Hamilton Thorne Inc.
    • Hi-Tech Solutions
    • Kitazato Corporation
    • Pride Angel
    • Rinovum Women's Health LLC
    • Rocket Medical plc
    • TenderNeeds Fertility LLC
    • Vitrolife AB
Product Code: SR112025A4023

The global artificial insemination market size reached USD 2.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.15% during 2025-2033. North America represents the largest region owing to the heightened awareness about the advantages of artificial insemination, the rising consumer per capita expenditure, and increasing healthcare expenditure. Moreover, increasing infertility rates, rapid lifestyle changes, and escalating prevalence of medical conditions represent some of the key factors driving the market demand.

The artificial insemination industry is facing tremendous changes driven by a cocktail of technological innovation, shifts in people's behavior, and increasing uses in various industries. The increasing use of data analytics in artificial insemination is one of the major trends transforming the market. Both in human fertility and in the livestock breeding industry, data analytics is being utilized to improve the efficiency and accuracy of artificial insemination procedures. In human fertility, clinics are now using big data and artificial intelligence (AI) algorithms to identify the optimal times for insemination, enhance sperm and egg selection, and maximize embryo culture environments. By using this data, fertility doctors can provide individualized treatment options tailored to the patient's unique requirements, thus increasing the possibilities of successful pregnancy. Machine learning (ML) and AI computer algorithms are also being utilized to sort through large data sets, which assist in further understanding infertility patterns and enhanced clinical outcomes.

Artificial Insemination Market Trends:

Technological Advancements in Artificial Insemination

Technological innovation is largely propelling the artificial insemination market through enhanced efficiency, success rates, and accessibility of artificial insemination procedures. In human fertility therapy, technological advancements in sperm selection, embryo culture, and cryopreservation are augmenting the accuracy and efficacy of artificial insemination. Methods like genetic screening and embryo grading are increasingly becoming sophisticated, translating to improved results for patients receiving artificial insemination-based reproductive therapies. For instance, the Ministry of Health and Prevention (MoHAP) announced that compulsory genetic testing will be implemented as part of the premarital screening program for all Emiratis intending to marry across the country, beginning in early January 2025. Moreover, in livestock breeding, the advancement of technology in semen freezing and storage is enabling improved preservation and longer utilization of quality semen. On-farm artificial insemination and automation are further enhancing the effectiveness of artificial insemination processes in agriculture to allow farmers to conduct insemination with reduced intervention.

Growing Usage of Artificial Insemination in Livestock Breeding

Growing usage of artificial insemination in animal breeding is significantly contributing to the growth of the market. Livestock farmers are increasingly using artificial insemination to enhance the quality of their herds, particularly in cattle, pigs, and poultry. Artificial insemination is helping farmers to selectively breed animals with superior characteristics like resistance to diseases, increased milk output, and quality meat, leading to enhanced productivity and profitability. This adoption is driven by increasing demand for quality meat and dairy because consumers are becoming concerned about the quality of food. Artificial insemination is also offering an answer for improving the herd genetics and handling the issue of inbreeding, especially in the livestock with low levels of genetic diversity. In 2025, the Union Cabinet sanctioned the Revised Rashtriya Gokul Mission (RGM) to enhance development in the livestock industry. The updated mission will be executed as a Central Sector part of the Development Programmes initiative, with an added expenditure of ₹1,000 crore, raising the overall funding to ₹3,400 crore for the 15th Finance Commission period from 2021-22 to 2025-26. The program will maintain its primary functions, which involve enhancing semen stations and artificial insemination networks, executing bull production and expedited breed enhancement programs with sex-sorted semen, promoting skill development and farmer education efforts, and creating Centres of Excellence while bolstering Central Cattle Breeding Farms.

Growing Fertility Treatment Demand

Growing demand for fertility treatments is one of the primary drivers of the artificial insemination sector, specifically in human reproductive medicine. The 2025 State of World Population (SOWP) Report from the United Nations Population Fund (UNFPA), named 'The Real Fertility Crisis', indicates that one in three adult Indians (36%) encounters unintended pregnancies, and 30% have unfulfilled wishes for having either more or fewer children. As societal attitudes change, most people and couples are opting to postpone childbearing because of personal or work-related issues, thus contributing to the rise in infertility cases. This transformation is driving the demand for assisted reproductive technologies (ART), such as artificial insemination. The increasing incidence of infertility, frequently associated with lifestyle factors, medical conditions, and environmental contaminants, is further stimulating the demand for fertility treatments. With increased interest in overcoming fertility issues, artificial insemination is increasingly proving to be a key solution because it is non-invasive and has high success rates.

Artificial Insemination Market Growth Drivers:

Government Policies and Support

Government assistance is contributing to the market growth by implementing various policies and programs that promote the use of artificial insemination technologies, mainly in agriculture and the health sector. In the agricultural sector, numerous governments are providing subsidies, monetary incentives, and grants to promote the use of artificial insemination in breeding. Such policies are enabling farmers to avail themselves of sophisticated reproductive technologies that would otherwise be too expensive for them. Also, governments are making investments in infrastructure to develop, for example artificial insemination artificial insemination training facilities for farmers and veterinary experts to ensure the presence of a skilled workforce to facilitate the adoption of artificial insemination. In the field of human fertility, governments are increasingly offering subsidies to fertility clinics, regulating artificial insemination-reliant reproductive technologies, and providing financial aid or insuring fertility treatments.

Social Acceptance and Cultural Shifts

Social acceptance and cultural shifts in attitudes toward family planning and fertility treatments are driving the demand for artificial insemination. With changing societal values, more people and couples are setting career aspirations, higher education, and self-improvement as top priorities, resulting in postponing marriage and having children. These trends are translating into increased use of fertility treatments, such as artificial insemination, as people are preferring to avoid natural conception later in life. The stigma regarding infertility and assisted reproductive technology is also slowly fading as people increasingly talk about their fertility issues and choose artificial insemination-based approaches. This change in the social attitudes is making artificial insemination a more accepted way to conceive. In the same way, artificial insemination is changing the face of livestock farming, becoming a mainstream technology with farmers welcoming its ability to enhance animal genetics, maximize efficiency, and minimize the carbon footprint.

Economic Benefits and Cost-Effectiveness

Economic conditions are becoming the driving force behind the artificial insemination industry, especially within livestock breeding. With the expense of traditional breeding techniques, for example, keeping extensive herds of bulls or incurring costs for natural mating, on the increase, artificial insemination is becoming a cost-cutting solution. Artificial insemination enables farmers to utilize quality genetics from leading bulls with no need for heavy infrastructure, keeping breeding expenses down to a fraction. This affordability is assisting farmers, particularly in developing countries, in enhancing the profitability and productivity of their farms. In the same way, in the market for human fertility, the affordability of artificial insemination over other assisted reproductive technologies, is making it a viable choice for most people.

Global Artificial Insemination Industry Segmentation:

Breakup by Type:

  • Intrauterine
  • Intracervical
  • Intravaginal
  • Intratubal

The intrauterine segment dominates the market

According to the artificial insemination market outlook, intrauterine insemination involves placing sperm directly into the uterus, increasing the chances of sperm reaching the egg for fertilization. IUI generally offers higher success rates, particularly when dealing with male infertility factors such as low sperm motility. This makes it a preferred option for many patients.

Breakup by Source Type:

  • AIH-Husband
  • AID-Donor

According to the artificial insemination market outlook report, AIH involves using the husband's (or male partner's) sperm for insemination, often after sperm preparation to optimize chances of fertilization. One of the primary drivers of AIH is male factor infertility, which can involve low sperm count, poor sperm motility, or abnormal sperm morphology. AIH is often used when the sperm is viable but needs to be concentrated or processed for better chances of fertilization. Moreover, AID involves using donor sperm, typically from a sperm bank, to inseminate the woman. This is often done when the male partner's sperm is not viable or in cases where the woman is single or in a same-sex relationship.

Breakup by End Use:

  • Hospitals and Clinics
  • Fertility Centers
  • Others

The fertility centers segment spearheads the market

According to the artificial insemination market forecast report, the demand for Artificial Insemination (AI) in fertility centers is driven by a combination of medical, technological, demographic, and social factors. Fertility centers play a critical role in providing specialized reproductive services, and they are at the forefront of delivering assisted reproductive technologies (ART) such as intrauterine insemination (IUI), intracervical insemination (ICI), and other AI procedures.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America dominates the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America dominates the market.

According to the artificial insemination market statistics, some of the factors accelerating the North America artificial insemination market include the surging awareness regarding the advantages of artificial insemination, the rising consumer per capita expenditure, and burgeoning healthcare expenditure. The rising infertility rates among both men and women, driven by lifestyle changes, stress, pollution, delayed childbearing, and certain medical conditions, are a major driver of the AI market. Infertility rates have steadily increased in the region, with many couples and individuals turning to artificial insemination as a solution. Moreover, in North America, many women are choosing to delay parenthood due to career, financial, or personal reasons. For instance, according to an article published by Forbes, over the last decade, as more women of all social groups have emphasized education and profession, deferring motherhood has become practically universal among American women. As maternal age increases, fertility declines, leading to more individuals seeking assisted reproductive technologies (ART), including artificial insemination, to conceive. According to the artificial insemination market research, this is augmenting the regional market.

Competitive Landscape:

The artificial insemination market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

  • Conceivex Inc.
  • FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation)
  • Genea Limited
  • Genus plc
  • Hamilton Thorne Inc.
  • Hi-Tech Solutions
  • Kitazato Corporation
  • Pride Angel
  • Rinovum Women's Health LLC
  • Rocket Medical plc
  • TenderNeeds Fertility LLC
  • Vitrolife AB

Key Questions Answered in This Report

  • 1.How big is the global artificial insemination market?
  • 2.What is the expected growth rate of the global artificial insemination market during 2025-2033?
  • 3.What are the key factors driving the global artificial insemination market?
  • 4.What has been the impact of COVID-19 on the global artificial insemination market?
  • 5.What is the breakup of the global artificial insemination market based on the type?
  • 6.What is the breakup of the global artificial insemination market based on the end use?
  • 7.What are the key regions in the global artificial insemination market?
  • 8.Who are the key players/companies in the global artificial insemination market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Insemination Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Intrauterine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intracervical
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Intravaginal
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Intratubal
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Source Type

  • 7.1 AIH-Husband
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 AID-Donor
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Fertility Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Conceivex Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Genea Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Genus plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Hamilton Thorne Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Hi-Tech Solutions
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Kitazato Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Pride Angel
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Rinovum Women's Health LLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Rocket Medical plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 TenderNeeds Fertility LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Vitrolife AB
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials

List of Figures

  • Figure 1: Global: Artificial Insemination Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Insemination Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Artificial Insemination Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Artificial Insemination Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Artificial Insemination Market: Breakup by Source Type (in %), 2024
  • Figure 6: Global: Artificial Insemination Market: Breakup by End Use (in %), 2024
  • Figure 7: Global: Artificial Insemination Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Artificial Insemination (Intrauterine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Artificial Insemination (Intrauterine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Artificial Insemination (Intracervical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Artificial Insemination (Intracervical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Artificial Insemination (Intravaginal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Artificial Insemination (Intravaginal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Artificial Insemination (Intratubal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Artificial Insemination (Intratubal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Artificial Insemination (AIH-Husband) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Artificial Insemination (AIH-Husband) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Artificial Insemination (AID-Donor) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Artificial Insemination (AID-Donor) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Artificial Insemination (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Artificial Insemination (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Artificial Insemination (Fertility Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Artificial Insemination (Fertility Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Artificial Insemination (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Artificial Insemination (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Artificial Insemination Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Artificial Insemination Industry: SWOT Analysis
  • Figure 76: Global: Artificial Insemination Industry: Value Chain Analysis
  • Figure 77: Global: Artificial Insemination Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Artificial Insemination Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Artificial Insemination Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Artificial Insemination Market Forecast: Breakup by Source Type (in Million USD), 2025-2033
  • Table 4: Global: Artificial Insemination Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 5: Global: Artificial Insemination Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Artificial Insemination Market: Competitive Structure
  • Table 7: Global: Artificial Insemination Market: Key Players